The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global ADHD Treatment Market Research Report 2024
Synopsis
Attention deficit and hyperactivity disorder (ADHD), commonly known as ADHD, refers to the occurrence of childhood,A group of syndromes characterized by marked difficulty concentrating, short attention span, hyperactivity, or impulsivity compared with children of the same age. To treat ADHD, the US FDA has approved two types of drugs: stimulants and non-stimulants. Stimulants include methylphenidate, amphetamines Amphetamine, non-stimulants including atomoxetine, guanfacine and clonidine.
Due to the COVID-19 pandemic, the global ADHD Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe ADHD Treatment market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe ADHD Treatment landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Stimulant accounting for % of the ADHD Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of ADHD Treatment include Takeda, Johnson & Johnson, N ovartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals and N oven Pharmaceuticals, etc. In terms of revenue, the global 3 largest players have a % market share of ADHD Treatment in 2021.
This report focuses on ADHD Treatment volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall ADHD Treatment market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global ADHD Treatment Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Distribution Channel. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Stimulant
Non-stimulant
Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Takeda
Johnson & Johnson
N ovartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
N oven Pharmaceuticals
Purdue Parma
Jiangsu Chia Tai Fenghai Pharmaceutical
Attention deficit and hyperactivity disorder (ADHD), commonly known as ADHD, refers to the occurrence of childhood,A group of syndromes characterized by marked difficulty concentrating, short attention span, hyperactivity, or impulsivity compared with children of the same age. To treat ADHD, the US FDA has approved two types of drugs: stimulants and non-stimulants. Stimulants include methylphenidate, amphetamines Amphetamine, non-stimulants including atomoxetine, guanfacine and clonidine.
Due to the COVID-19 pandemic, the global ADHD Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe ADHD Treatment market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe ADHD Treatment landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Stimulant accounting for % of the ADHD Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of ADHD Treatment include Takeda, Johnson & Johnson, N ovartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals and N oven Pharmaceuticals, etc. In terms of revenue, the global 3 largest players have a % market share of ADHD Treatment in 2021.
This report focuses on ADHD Treatment volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall ADHD Treatment market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global ADHD Treatment Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Distribution Channel. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Stimulant
Non-stimulant
Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Takeda
Johnson & Johnson
N ovartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
N oven Pharmaceuticals
Purdue Parma
Jiangsu Chia Tai Fenghai Pharmaceutical
Index1 ADHD Treatment Market Overview
1.1 Product Overview and Scope of ADHD Treatment
1.2 ADHD Treatment Segment by Type
1.2.1 Global ADHD Treatment Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 ADHD Treatment Segment by Distribution Channel
1.3.1 Global ADHD Treatment Sales Comparison by Distribution Channel: (2022-2028)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Global ADHD Treatment Market Size Estimates and Forecasts
1.4.1 Global ADHD Treatment Revenue 2017-2028
1.4.2 Global ADHD Treatment Sales 2017-2028
1.4.3 ADHD Treatment Market Size by Region: 2017 Versus 2021 Versus 2028
2 ADHD Treatment Market Competition by Manufacturers
2.1 Global ADHD Treatment Sales Market Share by Manufacturers (2017-2022)
2.2 Global ADHD Treatment Revenue Market Share by Manufacturers (2017-2022)
2.3 Global ADHD Treatment Average Price by Manufacturers (2017-2022)
2.4 Manufacturers ADHD Treatment Manufacturing Sites, Area Served, Product Type
2.5 ADHD Treatment Market Competitive Situation and Trends
2.5.1 ADHD Treatment Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest ADHD Treatment Players Market Share by Revenue
2.5.3 Global ADHD Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ADHD Treatment Retrospective Market Scenario by Region
3.1 Global ADHD Treatment Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global ADHD Treatment Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America ADHD Treatment Market Facts & Figures by Country
3.3.1 North America ADHD Treatment Sales by Country
3.3.2 North America ADHD Treatment Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe ADHD Treatment Market Facts & Figures by Country
3.4.1 Europe ADHD Treatment Sales by Country
3.4.2 Europe ADHD Treatment Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific ADHD Treatment Market Facts & Figures by Region
3.5.1 Asia Pacific ADHD Treatment Sales by Region
3.5.2 Asia Pacific ADHD Treatment Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America ADHD Treatment Market Facts & Figures by Country
3.6.1 Latin America ADHD Treatment Sales by Country
3.6.2 Latin America ADHD Treatment Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa ADHD Treatment Market Facts & Figures by Country
3.7.1 Middle East and Africa ADHD Treatment Sales by Country
3.7.2 Middle East and Africa ADHD Treatment Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global ADHD Treatment Historic Market Analysis by Type
4.1 Global ADHD Treatment Sales Market Share by Type (2017-2022)
4.2 Global ADHD Treatment Revenue Market Share by Type (2017-2022)
4.3 Global ADHD Treatment Price by Type (2017-2022)
5 Global ADHD Treatment Historic Market Analysis by Distribution Channel
5.1 Global ADHD Treatment Sales Market Share by Distribution Channel (2017-2022)
5.2 Global ADHD Treatment Revenue Market Share by Distribution Channel (2017-2022)
5.3 Global ADHD Treatment Price by Distribution Channel (2017-2022)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda ADHD Treatment Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Takeda ADHD Treatment Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson ADHD Treatment Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Johnson & Johnson ADHD Treatment Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 N ovartis
6.3.1 N ovartis Corporation Information
6.3.2 N ovartis Description and Business Overview
6.3.3 N ovartis ADHD Treatment Sales, Revenue and Gross Margin (2017-2022)
6.3.4 N ovartis ADHD Treatment Product Portfolio
6.3.5 N ovartis Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Corporation Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly ADHD Treatment Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Eli Lilly ADHD Treatment Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Tris Pharma
6.5.1 Tris Pharma Corporation Information
6.5.2 Tris Pharma Description and Business Overview
6.5.3 Tris Pharma ADHD Treatment Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Tris Pharma ADHD Treatment Product Portfolio
6.5.5 Tris Pharma Recent Developments/Updates
6.6 Neos Therapeutics
6.6.1 Neos Therapeutics Corporation Information
6.6.2 Neos Therapeutics Description and Business Overview
6.6.3 Neos Therapeutics ADHD Treatment Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Neos Therapeutics ADHD Treatment Product Portfolio
6.6.5 Neos Therapeutics Recent Developments/Updates
6.7 Mallinckrodt
6.6.1 Mallinckrodt Corporation Information
6.6.2 Mallinckrodt Description and Business Overview
6.6.3 Mallinckrodt ADHD Treatment Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Mallinckrodt ADHD Treatment Product Portfolio
6.7.5 Mallinckrodt Recent Developments/Updates
6.8 Amneal Pharmaceuticals
6.8.1 Amneal Pharmaceuticals Corporation Information
6.8.2 Amneal Pharmaceuticals Description and Business Overview
6.8.3 Amneal Pharmaceuticals ADHD Treatment Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Amneal Pharmaceuticals ADHD Treatment Product Portfolio
6.8.5 Amneal Pharmaceuticals Recent Developments/Updates
6.9 N oven Pharmaceuticals
6.9.1 N oven Pharmaceuticals Corporation Information
6.9.2 N oven Pharmaceuticals Description and Business Overview
6.9.3 N oven Pharmaceuticals ADHD Treatment Sales, Revenue and Gross Margin (2017-2022)
6.9.4 N oven Pharmaceuticals ADHD Treatment Product Portfolio
6.9.5 N oven Pharmaceuticals Recent Developments/Updates
6.10 Purdue Parma
6.10.1 Purdue Parma Corporation Information
6.10.2 Purdue Parma Description and Business Overview
6.10.3 Purdue Parma ADHD Treatment Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Purdue Parma ADHD Treatment Product Portfolio
6.10.5 Purdue Parma Recent Developments/Updates
6.11 Jiangsu Chia Tai Fenghai Pharmaceutical
6.11.1 Jiangsu Chia Tai Fenghai Pharmaceutical Corporation Information
6.11.2 Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Description and Business Overview
6.11.3 Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Product Portfolio
6.11.5 Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments/Updates
7 ADHD Treatment Manufacturing Cost Analysis
7.1 ADHD Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of ADHD Treatment
7.4 ADHD Treatment Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 ADHD Treatment Distributors List
8.3 ADHD Treatment Customers
9 ADHD Treatment Market Dynamics
9.1 ADHD Treatment Industry Trends
9.2 ADHD Treatment Market Drivers
9.3 ADHD Treatment Market Challenges
9.4 ADHD Treatment Market Restraints
10 Global Market Forecast
10.1 ADHD Treatment Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of ADHD Treatment by Type (2023-2028)
10.1.2 Global Forecasted Revenue of ADHD Treatment by Type (2023-2028)
10.2 ADHD Treatment Market Estimates and Projections by Distribution Channel
10.2.1 Global Forecasted Sales of ADHD Treatment by Distribution Channel (2023-2028)
10.2.2 Global Forecasted Revenue of ADHD Treatment by Distribution Channel (2023-2028)
10.3 ADHD Treatment Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of ADHD Treatment by Region (2023-2028)
10.3.2 Global Forecasted Revenue of ADHD Treatment by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global ADHD Treatment Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global ADHD Treatment Sales Growth Rate Comparison by Distribution Channel (2022-2028) & (K Units) & (US$ Million)
Table 3. Global ADHD Treatment Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global ADHD Treatment Market Competitive Situation by Manufacturers in 2021
Table 5. Global ADHD Treatment Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global ADHD Treatment Sales Market Share by Manufacturers (2017-2022)
Table 7. Global ADHD Treatment Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global ADHD Treatment Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market ADHD Treatment Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers ADHD Treatment Manufacturing Sites and Area Served
Table 11. Manufacturers ADHD Treatment Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global ADHD Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in ADHD Treatment as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global ADHD Treatment Sales by Region (2017-2022) & (K Units)
Table 16. Global ADHD Treatment Sales Market Share by Region (2017-2022)
Table 17. Global ADHD Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global ADHD Treatment Revenue Market Share by Region (2017-2022)
Table 19. North America ADHD Treatment Sales by Country (2017-2022) & (K Units)
Table 20. North America ADHD Treatment Sales Market Share by Country (2017-2022)
Table 21. North America ADHD Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America ADHD Treatment Revenue Market Share by Country (2017-2022)
Table 23. Europe ADHD Treatment Sales by Country (2017-2022) & (K Units)
Table 24. Europe ADHD Treatment Sales Market Share by Country (2017-2022)
Table 25. Europe ADHD Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe ADHD Treatment Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific ADHD Treatment Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific ADHD Treatment Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific ADHD Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific ADHD Treatment Revenue Market Share by Region (2017-2022)
Table 31. Latin America ADHD Treatment Sales by Country (2017-2022) & (K Units)
Table 32. Latin America ADHD Treatment Sales Market Share by Country (2017-2022)
Table 33. Latin America ADHD Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America ADHD Treatment Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa ADHD Treatment Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa ADHD Treatment Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa ADHD Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa ADHD Treatment Revenue Market Share by Country (2017-2022)
Table 39. Global ADHD Treatment Sales by Type (2017-2022) & (K Units)
Table 40. Global ADHD Treatment Sales Market Share by Type (2017-2022)
Table 41. Global ADHD Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global ADHD Treatment Revenue Share by Type (2017-2022)
Table 43. Global ADHD Treatment Price by Type (2017-2022) & (US$/Unit)
Table 44. Global ADHD Treatment Sales (K Units) by Distribution Channel (2017-2022)
Table 45. Global ADHD Treatment Sales Market Share by Distribution Channel (2017-2022)
Table 46. Global ADHD Treatment Revenue by Distribution Channel (2017-2022) & (US$ Million)
Table 47. Global ADHD Treatment Revenue Share by Distribution Channel (2017-2022)
Table 48. Global ADHD Treatment Price by Distribution Channel (2017-2022) & (US$/Unit)
Table 49. Takeda Corporation Information
Table 50. Takeda Description and Business Overview
Table 51. Takeda ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Takeda ADHD Treatment Product
Table 53. Takeda Recent Developments/Updates
Table 54. Johnson & Johnson Corporation Information
Table 55. Johnson & Johnson Description and Business Overview
Table 56. Johnson & Johnson ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Johnson & Johnson ADHD Treatment Product
Table 58. Johnson & Johnson Recent Developments/Updates
Table 59. N ovartis Corporation Information
Table 60. N ovartis Description and Business Overview
Table 61. N ovartis ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. N ovartis ADHD Treatment Product
Table 63. N ovartis Recent Developments/Updates
Table 64. Eli Lilly Corporation Information
Table 65. Eli Lilly Description and Business Overview
Table 66. Eli Lilly ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Eli Lilly ADHD Treatment Product
Table 68. Eli Lilly Recent Developments/Updates
Table 69. Tris Pharma Corporation Information
Table 70. Tris Pharma Description and Business Overview
Table 71. Tris Pharma ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Tris Pharma ADHD Treatment Product
Table 73. Tris Pharma Recent Developments/Updates
Table 74. Neos Therapeutics Corporation Information
Table 75. Neos Therapeutics Description and Business Overview
Table 76. Neos Therapeutics ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Neos Therapeutics ADHD Treatment Product
Table 78. Neos Therapeutics Recent Developments/Updates
Table 79. Mallinckrodt Corporation Information
Table 80. Mallinckrodt Description and Business Overview
Table 81. Mallinckrodt ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Mallinckrodt ADHD Treatment Product
Table 83. Mallinckrodt Recent Developments/Updates
Table 84. Amneal Pharmaceuticals Corporation Information
Table 85. Amneal Pharmaceuticals Description and Business Overview
Table 86. Amneal Pharmaceuticals ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Amneal Pharmaceuticals ADHD Treatment Product
Table 88. Amneal Pharmaceuticals Recent Developments/Updates
Table 89. N oven Pharmaceuticals Corporation Information
Table 90. N oven Pharmaceuticals Description and Business Overview
Table 91. N oven Pharmaceuticals ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. N oven Pharmaceuticals ADHD Treatment Product
Table 93. N oven Pharmaceuticals Recent Developments/Updates
Table 94. Purdue Parma Corporation Information
Table 95. Purdue Parma Description and Business Overview
Table 96. Purdue Parma ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Purdue Parma ADHD Treatment Product
Table 98. Purdue Parma Recent Developments/Updates
Table 99. Jiangsu Chia Tai Fenghai Pharmaceutical Corporation Information
Table 100. Jiangsu Chia Tai Fenghai Pharmaceutical Description and Business Overview
Table 101. Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Jiangsu Chia Tai Fenghai Pharmaceutical ADHD Treatment Product
Table 103. Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments/Updates
Table 104. Production Base and Market Concentration Rate of Raw Material
Table 105. Key Suppliers of Raw Materials
Table 106. ADHD Treatment Distributors List
Table 107. ADHD Treatment Customers List
Table 108. ADHD Treatment Market Trends
Table 109. ADHD Treatment Market Drivers
Table 110. ADHD Treatment Market Challenges
Table 111. ADHD Treatment Market Restraints
Table 112. Global ADHD Treatment Sales Forecast by Type (2023-2028) & (K Units)
Table 113. Global ADHD Treatment Sales Market Share Forecast by Type (2023-2028)
Table 114. Global ADHD Treatment Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 115. Global ADHD Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 116. Global ADHD Treatment Sales Forecast by Distribution Channel (2023-2028) & (K Units)
Table 117. Global ADHD Treatment Sales Market Share Forecast by Distribution Channel (2023-2028)
Table 118. Global ADHD Treatment Revenue Forecast by Distribution Channel (2023-2028) & (US$ Million)
Table 119. Global ADHD Treatment Revenue Market Share Forecast by Distribution Channel (2023-2028)
Table 120. Global ADHD Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 121. Global ADHD Treatment Sales Market Share Forecast by Region (2023-2028)
Table 122. Global ADHD Treatment Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 123. Global ADHD Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of ADHD Treatment
Figure 2. Global ADHD Treatment Market Share by Type in 2021 & 2028
Figure 3. Stimulant Product Picture
Figure 4. Non-stimulant Product Picture
Figure 5. Global ADHD Treatment Market Share by Distribution Channel in 2021 & 2028
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Global ADHD Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global ADHD Treatment Market Size (2017-2028) & (US$ Million)
Figure 10. Global ADHD Treatment Sales (2017-2028) & (K Units)
Figure 11. ADHD Treatment Sales Share by Manufacturers in 2021
Figure 12. Global ADHD Treatment Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest ADHD Treatment Players: Market Share by Revenue in 2021
Figure 14. ADHD Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global ADHD Treatment Sales Market Share by Region (2017-2022)
Figure 16. Global ADHD Treatment Sales Market Share by Region in 2021
Figure 17. Global ADHD Treatment Revenue Market Share by Region (2017-2022)
Figure 18. Global ADHD Treatment Revenue Market Share by Region in 2021
Figure 19. United States ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Colombia ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE ADHD Treatment Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of ADHD Treatment by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of ADHD Treatment
Figure 44. Manufacturing Process Analysis of ADHD Treatment
Figure 45. ADHD Treatment Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
